Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369446 · ClinicalTrials.gov registry record
Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage
A clinical trial, sponsored by Progyny.
- Completed
- Registry status
- 160
- Enrollment target
NCT01369446: Completed study, sponsored by Progyny.
NCT01369446 is a clinical trial that has completed, run by Progyny. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01369446 has completed, sponsored by Progyny.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that the Eeva System may be used to identify embryos on Day 2 that are most likely to form blastocysts.
Primary Outcome
Imaging data will be manually analyzed to validate parameters previously determined to be predictive of blastocyst formation.
Interventions
- DEVICE Eeva System Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-04 |
What the finished NCT01369446 record still lists
NCT01369446 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Eeva System Study is the first listed.
NCT01369446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01369446 about?
NCT01369446 is a clinical study titled "Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage". The purpose of this study is to demonstrate that the Eeva System may be used to identify embryos on Day 2 that are most likely to form blastocysts.
What is the current status of trial NCT01369446?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2011-06. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01369446?
The interventions under investigation include: Eeva System Study (DEVICE).
Who is sponsoring clinical trial NCT01369446?
This trial is sponsored by Progyny, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia